Canlyniadau Chwilio - Pedro Castelo‐Branco
- Dangos 1 - 20 canlyniadau o 33
- Ewch i'r Dudalen Nesaf
-
1
Parks in peril: people, politics and protected areas gan Silveira, Pedro Castelo Branco
Cyhoeddwyd 2001Online -
2
-
3
-
4
-
5
-
6
-
7
-
8
-
9
-
10
Comparative outcome assessment of epidermal growth factor receptor tyrosine kinase inhibitors for the treatment of advanced non-small-cell lung cancer: a network meta-analysis gan Ramon Andrade de Mello, Carles Escriu, Pedro Castelo‐Branco, Paloma Cabral, Giannis Mountzios, Gilberto Lopes, Pedro Madureira
Cyhoeddwyd 2017Artigo -
11
-
12
-
13
New Target Therapies in Advanced Non-Small Cell Lung Cancer: A Review of the Literature and Future Perspectives gan Ramon Andrade de Mello, Nathália Moisés Neves, Hakaru Tadokoro, Giovanna Araújo Amaral, Pedro Castelo‐Branco, Victor André de Almeida Zia
Cyhoeddwyd 2020Revisão -
14
MetaLanc9 as a novel biomarker for non-small cell lung cancer: promising treatments via a PGK1-activated AKT/mTOR pathway gan Ramon Andrade de Mello, Pedro Nazareth Aguiar, Hakaru Tadokoro, Tállita Meciany Farias-Vieira, Pedro Castelo‐Branco, Gilberto Lopes, Daniel Humberto Pozza
Cyhoeddwyd 2018Carta -
15
-
16
Immunotherapy in Patients with Advanced Non-Small Cell Lung Cancer Lacking Driver Mutations and Future Perspectives gan Ramon Andrade de Mello, Rafael Voscaboinik, João Vittor Pires Luciano, Rafaela Vilela Cremonese, Giovanna Araújo Amaral, Pedro Castelo‐Branco, Γεώργιος Αντωνίου
Cyhoeddwyd 2021Revisão -
17
Screening for Colorectal Cancer Leading into a New Decade: The “Roaring ‘20s” for Epigenetic Biomarkers? gan Hélder Almeida-Lousada, André Mestre, Sara Ramalhete, Aryeh J. Price, Ramon Andrade de Mello, Ana Marreiros, Ricardo Pires das Neves, Pedro Castelo‐Branco
Cyhoeddwyd 2021Revisão -
18
The Role of MET Inhibitor Therapies in the Treatment of Advanced Non-Small Cell Lung Cancer gan Ramon Andrade de Mello, Nathália Moisés Neves, Giovanna Araújo Amaral, Estela Gudin Lippo, Pedro Castelo‐Branco, Daniel Humberto Pozza, Carla Chizuru Tajima, Γεώργιος Αντωνίου
Cyhoeddwyd 2020Revisão -
19
Current and future aspects of TIM-3 as biomarker or as potential targeted in non-small cell lung cancer scope: is there a role in clinical practice? gan Ramon Andrade de Mello, Jinhui Zhu, Jairo Iavelberg, Artur Henrique Potim, Débora Simonetti, José Antônio Silva, Pedro Castelo‐Branco, Daniel Humberto Pozza, Carla Chizuru Tajima, Maria Tolia, Georgio Antoniou
Cyhoeddwyd 2020Carta -
20
Bifosfonatos: tipos, mecanismos de ação e efeitos colaterais. Revisão da literatura para orientação de profissionais e estudantes das áreas médica e odontológica gan Viviann Ruocco Vetucci, Monique Bergantim, Daniel Pedro Castelo Branco Lopes, Diego Nunes Pim, Gustavo Junqueira de Almeida, Rodrigo Nascimento Turano de Mattos, Tiago Varesche Silva, Ana Paula de Souza Faloni
Cyhoeddwyd 2023Artigo
Offerynnau Chwilio:
Pynciau Perthynol
Biology
Medicine
Cancer research
Cancer
Genetics
Gene
Oncology
Internal medicine
Epigenetics
Lung cancer
Biochemistry
Bioinformatics
DNA methylation
Disease
Gene expression
Cancer cell
Cell biology
DNA
Immunology
Pathology
Telomere
Carcinogenesis
CpG site
Methylation
Molecular biology
Mutation
Telomerase
Telomerase reverse transcriptase
Adverse effect
Biomarker